# Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer

> **NCT01006785** · PHASE2 · TERMINATED · sponsor: **Dexa Medica Group** · enrollment: 15 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** DLBS1425
- **DRUG:** DLBS1425

## Key facts

- **NCT ID:** NCT01006785
- **Lead sponsor:** Dexa Medica Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-08
- **Primary completion:** 2012-03
- **Final completion:** 2012-03
- **Target enrollment:** 15 (ACTUAL)
- **Why stopped:** The study was terminated due to difficulty of find eligible subjects
- **Last updated:** 2012-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01006785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01006785, "Efficacy and Safety of DLBS1425 in Subjects With Advanced/Metastatic Breast Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01006785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*